Bertil Abrahamsson - Concepedia

Author

Bertil Abrahamsson

AstraZeneca (Sweden)ORCID

Also Known As

B ABRAHAMSSON, B Abrahamsson, B. Abrahamsson, Bertil Abrahamsson, Bertil S. I. Abrahamsson

166

Publications

8.6K

Citations

H-Index

100

Concepts

All Affiliations

AstraZeneca (Sweden)Uppsala University Goethe University Frankfurt AstraZeneca (United Kingdom)International Pharmaceutical Federation

About

Bertil Abrahamsson is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	69	4.6K
2	Engineering	6	6	284
3	Health Sciences	5	5	320
4	Public Health	5	5	975
5	Education	1	1	31

Bertil Abrahamsson

100

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Characterization of the Human Upper Gastrointestinal Contents Under Conditions Simulating Bioavailability/Bioequivalence Studies Lida Kalantzi, Konstantinos Goumas, V. Kalioras, Pharmaceutical Research NutritionPhysiologyGastroenterologyDigestive TractGut Barrier	2005	647
The Effects of Food on the Dissolution of Poorly Soluble Drugs in Human and in Model Small Intestinal Fluids Eva Persson, Ann-Sofie Gustafsson, Anders S. Carlsson, Pharmaceutical Research NutritionMedicineFood DigestionGastroenterologyPoorly Soluble Drugs	2005	264
Gastric flow and mixing studied using computer simulation Anupam Pal, K. Indireshkumar, Werner Schwizer, Proceedings of the Royal Society B Biological Sciences	2004	246
A stomach road or “Magenstrasse” for gastric emptying Anupam Pal, James G. Brasseur, Bertil Abrahamsson Journal of Biomechanics GastroenterologyStomach RoadSurgeryGastrointestinal PathologyUpper Gastrointestinal Surgery	2006	180
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: Application of the mechanistic absorption model GI-Sim Erik Sjögren, Jan Westergren, Iain Grant, European Journal of Pharmaceutical Sciences Gastrointestinal Drug AbsorptionGastrointestinal PharmacologyMedicineBioanalysisGastroenterology	2013	167
Canine Intestinal Contents vs. Simulated Media for the Assessment of Solubility of Two Weak Bases in the Human Small Intestinal Contents Lida Kalantzi, Eva Persson, Britta Polentarutti, Pharmaceutical Research Animal PhysiologyNutritionMedicineBioanalysisPhysiology	2006	157
Toward an Increased Understanding of the Barriers to Colonic Drug Absorption in Humans: Implications for Early Controlled Release Candidate Assessment Christer Tannergren, A. Bergendal, Hans Lennernäs, Molecular Pharmaceutics Substance AbuseCytochrome P450 3APermeability MarkersPharmacological StudyMedicine	2009	139
Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug Sara Carlert, Anna Pålsson, Gunilla Hanisch, Pharmaceutical Research Pharmacokinetic ModelingGastrointestinal PharmacologyPharmacologyGastroenterologyClinical Gastroenterology	2010	135
Characterization of the Contents of Ascending Colon to Which Drugs are Exposed After Oral Administration to Healthy Adults Amalia Diakidou, Maria Vertzoni, Konstantinos Goumas, Pharmaceutical Research Substance AbuseGastrointestinal PharmacologyMedicineGastroenterologyOral Administration	2009	133
On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid Tiago Sousa, Vipul Yadav, Vanessa Zann, Journal of Pharmaceutical Sciences Colonic Bacterial MetabolismBiochemistryMicrobiologyDigestive TractMicrobiome	2014	130

Page 1